imidazole has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayatigolkhatmi, K | 1 |
| Padroni, G | 1 |
| Su, W | 1 |
| Fang, L | 1 |
| Gómez-Castañeda, E | 1 |
| Hsieh, YC | 1 |
| Jackson, L | 1 |
| Pellicano, F | 1 |
| Burley, GA | 1 |
| Jørgensen, HG | 1 |
1 other study available for imidazole and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
An investigation of targeted inhibition of transcription factor activity with pyrrole imidazole polyamide (PA) in chronic myeloid leukemia (CML) blast crisis cells.
Topics: Antineoplastic Agents; Blast Crisis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationshi | 2019 |